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(0.018; 90%CI). The one- and two-period lagged PAT_AP (0.451
& 0.297; 99%CI) and LIFEXP65 (0.018; 99%CI) were highly
signiﬁcant and PHARM_R&D (0.166; 90%CI) was marginally
signiﬁcant. CONCLUSIONS: In contrast to effects in HCE in pre-
vious studies there is an ageing effect (pull factor) causing rising
EPD as well as for pharmaceutical innovations. Additionally, we
found a push factor, namely R&D expenditures of pharmaceuti-
cal industry causing increasing EPD and innovations. Increasing
doctors’ consultations lead to decreasing EPD maybe caused by
successful application of lower medical therapies or by additional
following non-medical therapies which are not affecting EPD.
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In France, 97% of children under age of 3 turn to a GP at least
once a year. The GP/child encounter beneﬁts from a particular
status -no gate keeper constraint, baby extra fee- even if neither
the nature nor the economic burden of this activity have been
yet studied. OBJECTIVES: This study aimed to: 1/ analyse the
nature of the activity for children in General Practice 2/ ﬁnd out
the determinants of the prescription decision. METHOD: We got
data from a representative sample of 922 French GPs (BKL-
Thalès panel). Information was directly collected on the basis of
60 consecutives visits per GP, through a patient management
software. We only picked children visits. In addition to standard
GPs and patients characteristics, other data were also collected
on the child: health insurance status, status in the GP’s practice:
regular / new) and on the visit (length, reasons for encounter,
prescription of drugs . . .). We use the Hierarchical Linear
Models to identify the determinants of the prescription at the
respective level of children and GPs. RESULTS: Activity is highly
concentrated: Upper Respiratory Tract Infections represent
54.8% of the 6652 visits. Obviously URTI favours prescription
decision by 3.96(OR) [p < 0.0001] and more generally an acute
pathology by 3.26(OR) [p < 0.0001]. GPs prescribe on average
2 medicines per visit (even if 25.1% did not lead to any pre-
scription) but surprisingly male prescribe much more than
female: 2.01(OR) [p < 0.0062]. Long visits (over 15 minutes)
lead more often to a drugs prescription: 1.80(OR) [p < 0.0001].
Furthermore, a child under age of 6 is more likely to receive a
drugs prescription 1.66(OR) [p < 0.0001]. CONCLUSION: The
diagnoses and the child age clearly explain drugs prescription
and unexpectedly GPs sex takes signiﬁcantly part in the decision
of prescription.
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OBJECTIVES: Monte Negro Republic health fund is the only
institution in Monte Negro dealing with health insurance. It
covers approximately 640,000 inhabitants. As the drug expences
in Monte Negro reached 30% of total health expences during
2003, informational system (IS) in outpatient health practice was
introduced. This system enabled the total control and follow up
in area of use of drugs covered ﬁnancially by the health fund.
METHODS: IS bind together pharmacies, health care institu-
tions, databases of persons with health insurance, drugs, and
health care providers. Through unique code system automatic
information ﬂow imported through bar code was enabled.
RESULTS: In the ﬁrst year after introduction of IS (2004) the
3.6 mil of EUR was saved, what is 30.6% les than in 2000 year.
During the 2005 year €2.2 million, or 18.76% less amount of
money was spent than in 2002 year. The increase of expenditure
for the drugs in 2005 when compare with 2004 could be
explained by better supply of pharmacies during 2005. The next
reason was the increase of number of insured persons for 6.4%
and the third reason was weaker control of drug use and absence
of interventions after analysis of drug use. During 2005, the
bigest percentage of money from the fund was spent on insured
patients older than over 65 years, with group C being the ﬁrst
place, being 31.3% of total expences. CONCLUSIONS: Intro-
duction of informational system rationalized outpatient drug use
and enabled application of international standards. The greatest
decrease of drug use was realized during the ﬁrst year after 
the introduction of reforms. The bigest ﬁnancial spenders are
patients older than 65 years, and the group C of drugs. The 
permanent control and intervention in the ﬁeld of drug use are
necessary.
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A very difﬁcult objective to be reached in the ﬁeld of outcome
research is to measure Quality of Life (QoL) in paediatric pop-
ulations. Non negligible semantic ambiguity has been shown to
characterize health perceptions and descriptions in developmen-
tal age. OBJECTIVE: As a part of the project aimed at devel-
oping a valid and reliable Italian version of EQ-5D suitable for
children—i.e. the Italian Child-Fiendly EQ-5D (CF-EQ-5D)
project—statistically based lexical analyses are applied. The aim
of the analyses is to identify the semantic ﬁeld associated to each
item of the instrument, with the ﬁnal purpose of formulating
comprehensible, valid, unambiguous, and reliable items in Italian
CF-EQ-5D. METHODS: Thirty children/adolescents (aged 8–15
years, all native speakers, resident in different parts of Italy),
gave their informed consent and self-completed an Italian version
of CF-EQ-5D (from a forward-backward-forward translation
method). Then participants were submitted to face-to-face and
tape-recorded cognitive interviews and were invited to generate
word associations in response to the core words of each item.
RESULTS: The resulting textual corpus (normalized and lexi-
calized) is submitted to descriptive and multivariate statistical
analyses ﬁt for textual data. An analysis of lexical speciﬁcity is
calculated in order to illustrate the general features of the vocab-
ulary generated by respondents. In a second step, Multiple Cor-
respondence Analysis is performed on a words*contexts matrix,
with socio-demographic characteristics of the participants as
illustrative variables. CONCLUSIONS: Preliminary outcomes
suggest that children and adolescents associate non-univocal
semantic ﬁelds to core aspects of the health-related lexicon.
Implications for the developing and improving of the Italian
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Child-Friendly version of EQ-5D will be discussed to realize the
ﬁnal version of the questionnaire.
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OBJECTIVES: There is a lack of a validated QoL questionnaire
assessing the psychological burden and treatment beneﬁts of bed-
wetting as evaluated by the child. This abstract reports the results
of the initial validation tests for such a questionnaire. It is being
developed in accordance with the validation standards of the
ICIQ. METHODS: A literature review was conducted and led
to quantitative interviews with 28 children suffering from Noc-
turnal Enuresis and 28 pairs of parents. Consequently a ques-
tionnaire including 20 questions was developed and tested in a
multinational Randomised Clinical Trial completed by 196 chil-
dren and 196 parents in antidiuretic treatment before and during
the trial. RESULTS: Based on review and interviews, a list of
issues was identiﬁed: Social isolation, emotional distress, low
self-esteem, problems in parent-child relation, delayed indepen-
dence and fear of being teased at school and home. Two or more
questions were developed for each of the six issues to add room
for elimination of poorly performing questions. The RCT data
indicated promising cluster effect, i.e. the well treated children
showed a high QoL, and the questions seemed test-retest con-
sistent. Some questions yield a high level of missing answers.
CONCLUSION: The tests led to reformulation of the questions
yielding missing answers and the questionnaire is now ready for
the coming validation, including sensitivity analysis and item
reduction. We are convinced that future research in Nocturnal
Enuresis will proﬁt from the ﬁnal questionnaire.
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OBJECTIVE: Duration of vaginal estrogen therapy (VET) may
vary. This study sought to compare and contrast treatment dura-
tion of women prescribed vaginal tablets (VT) or vaginal creams
(VC) in clinical trials with that in clinical practice. METHODS:
Adults initiating VET between January and June, 2004 in 57
managed care plans (PharMetrics database) in the United States
were identiﬁed and followed for up to 10 months to examine
their treatment duration. A Kaplan-Meier analysis was per-
formed to obtain average and median time to discontinuation
for individuals treated with VT or VC. A weighted average of
treatment duration was calculated for a total of seven clinical
trials identiﬁed in the literature. These results were stratiﬁed by
study inclusion criteria. Differences in average treatment duara-
tion were statistically tested using t-tests. RESULTS: Of 5599
patients undergoing VET (mean age = 54 ± 9.1 years), 4355
(77.8%) received VC and 1244 (22.2%) received VT. Patients
prescribed VT had a signiﬁcantly longer average (median) treat-
ment compared to patients prescribed VC [(198.5 ± 82.4 days
(221 days) vs. 177.1 ± 86.7 days (190 days)); p < 0.01)]. This
duration in clinical practice was signiﬁcantly longer than that in
seven clinical trials [165 days (240 days for three trials of both
VC and VT; 90 days for two VT-only studies; and 69 days for
two VC-only studies)]. CONCLUSIONS: Duration of VET was
longer in a real-world clinical practice setting than in clinical
trials. Moreover, subjects treated with VT exhibited signiﬁcantly
longer treatment duration than subjects treated with VC. Possi-
ble factors explaining longer duration with VT include ease of
use, reduced messiness, accurate dosing resulting in improved
effectiveness and fewer adverse events, and consequently
improved quality of life. Future studies should prospectively
examine factors associated with these differences.
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OBJECTIVES: Nocturnal enuresis (NE) can pose signiﬁcant psy-
chological burden on children’s self-esteem and quality of life
(QoL). Therefore, patient-reported outcome (PRO) measure-
ment is essential to fully understand the burden posed by NE
and the beneﬁts of treating this condition. To our knowledge, it
has not been investigated which instruments should be used to
assess the psychological burden of NE. The aim of this study was
to identify and evaluate PRO instruments used in children with
NE. METHODS: A literature search of Medline and other data-
bases was conducted to identify publications from 1995–2006
which contained PRO instruments used in children with NE.
RESULTS: 40 studies and 32 PRO instruments were identiﬁed.
Instruments were evaluated based on psychometric properties
and responsiveness to change. Some studies used several PRO
instruments. The Child Behavior Checklist was the most 
commonly used instrument (8/40 studies, 20%). Measures of
self-esteem were used in 11/40 studies (28%). No generic QoL
measures were used in these trials. No disease-speciﬁc PRO
instruments were found to be fully validated in the NE. popula-
tion. Currently, a new disease-speciﬁc QoL questionnaire is in
development for NE. CONCLUSIONS: The results of this study
highlight the lack of patient-reported disease-speciﬁc PRO mea-
sures to assess the burden and treatment beneﬁts of NE. A new
disease-speciﬁc instrument may be able to ﬁll this gap.
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OBJECTIVES: To compare Finnish patients with erectile dys-
function (ED) and men from the Finnish general population in
measures of self-reported Health-Related QOL (HRQoL) and
satisfaction with life, and to investigate whether switching
patients from current oral ED medication to tadalaﬁl impacts
these measures. METHODS: A total of 202 Finnish men over
18 years successfully treated with oral ED prescription medica-
tion (tadalaﬁl excluded) voluntarily entered this multicenter,
open-label, one-arm, 3-month study. Upon enrollment, patients
discontinued their previous therapy and were started on tadalaﬁl
10 or 20 mg (dose determined by investigator) on demand.
Outcome was measured using the 15D and Life Satisfaction-11
(LiSat-11) checklists. 15D is a generic, comprehensive, 15-
dimensional, standardized, self-administered measure of HRQoL
